The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trollmo, C.
Right arrow Articles by Huber, B. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trollmo, C.
Right arrow Articles by Huber, B. T.
The Journal of Immunology, 2001, 166: 5286-5291.
Copyright © 2001 by The American Association of Immunologists

Molecular Mimicry in Lyme Arthritis Demonstrated at the Single Cell Level: LFA-1{alpha}L Is a Partial Agonist for Outer Surface Protein A-Reactive T Cells1

Christina Trollmo2,*, Abbie L. Meyer2,{dagger}, Allen C. Steere{ddagger}, David A. Hafler* and Brigitte T. Huber3,{dagger}

* Laboratory of Molecular Immunology, Center for Neurologic Diseases, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115; {dagger} Department of Pathology, and {ddagger} Division of Rheumatology/Immunology, Tufts University School of Medicine, New England Medical Center, Boston, MA 02111

Antibiotic treatment-resistant Lyme arthritis is a chronic inflammatory joint disease that follows infection with Borrelia burgdorferi (Bb). A marked Ab and T cell response to Bb outer surface protein A (OspA) often develops during prolonged episodes of arthritis. Furthermore, cross-reaction between the bacterial OspA and human LFA-1{alpha}L at the T cell level and the inability to detect Bb in the joint implicate an autoimmune mechanism. To analyze the nature of response to OspA and LFA-1{alpha}L, we used OspA-specific T cell hybrids from DR4 transgenic mice, as well as cloned human cells specific for OspA165–184, the immunodominant epitope, from five DRB1*0401+ patients, using OspA-MHC class II tetramers. Although OspA165–184 stimulated nearly all OspA-specific human T cell clones tested to proliferate and secrete IFN-{gamma} and IL-13, LFA-1{alpha}L326–345 stimulated ~10% of these clones to proliferate and a greater percentage to secrete IL-13. Assays with LFA- or OspA-DR4 monomers revealed that higher concentrations of LFA-DR4 were needed to stimulate dual-reactive T cell hybrids. Our analysis at the clonal level demonstrates that human LFA-1{alpha}L326–345 behaves as a partial agonist, perhaps playing a role in perpetuating symptoms of arthritis.




This article has been cited by other articles:


Home page
J. Immunol.Home page
P. Kannian, E. E. Drouin, L. Glickstein, W. W. Kwok, G. T. Nepom, and A. C. Steere
Decline in the Frequencies of Borrelia burgdorferi OspA161 175-Specific T Cells after Antibiotic Therapy in HLA-DRB1*0401-Positive Patients with Antibiotic-Responsive or Antibiotic-Refractory Lyme Arthritis
J. Immunol., November 1, 2007; 179(9): 6336 - 6342.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Parra-Lopez, J. M. Calvo-Calle, T. O. Cameron, L. E. Vargas, L. M. Salazar, M. E. Patarroyo, E. Nardin, and L. J. Stern
Major Histocompatibility Complex and T Cell Interactions of a Universal T Cell Epitope from Plasmodium falciparum Circumsporozoite Protein
J. Biol. Chem., May 26, 2006; 281(21): 14907 - 14917.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
A. C. Steere, W. Klitz, E. E. Drouin, B. A. Falk, W. W. Kwok, G. T. Nepom, and L. A. Baxter-Lowe
Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide
J. Exp. Med., April 17, 2006; 203(4): 961 - 971.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
M. E. Aguero-Rosenfeld, G. Wang, I. Schwartz, and G. P. Wormser
Diagnosis of Lyme Borreliosis
Clin. Microbiol. Rev., July 1, 2005; 18(3): 484 - 509.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Ghosh, A. C. Steere, B. D. Stollar, and B. T. Huber
In Situ Diversification of the Antibody Repertoire in Chronic Lyme Arthritis Synovium
J. Immunol., March 1, 2005; 174(5): 2860 - 2869.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. A. Willett, A. L. Meyer, E. L. Brown, and B. T. Huber
An effective second-generation outer surface protein A-derived Lyme vaccine that eliminates a potentially autoreactive T cell epitope
PNAS, February 3, 2004; 101(5): 1303 - 1308.
[Abstract] [Full Text] [PDF]


Home page
CROBMHome page
F. Goulhen, D. Grenier, and D. Mayrand
ORAL MICROBIAL HEAT-SHOCK PROTEINS AND THEIR POTENTIAL CONTRIBUTIONS TO INFECTIONS
Critical Reviews in Oral Biology & Medicine, November 1, 2003; 14(6): 399 - 412.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. S. Pikas, E. L. Brown, S. Gurusiddappa, L. Y. Lee, Y. Xu, and M. Hook
Decorin-binding Sites in the Adhesin DbpA from Borrelia burgdorferi: A SYNTHETIC PEPTIDE APPROACH
J. Biol. Chem., August 15, 2003; 278(33): 30920 - 30926.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A. C. Steere
Lyme Disease
N. Engl. J. Med., July 12, 2001; 345(2): 115 - 125.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.